Literature DB >> 2904703

Engraftment of immune-deficient mice with human hematopoietic stem cells.

S Kamel-Reid1, J E Dick.   

Abstract

A system in which immune-deficient mice are repopulated with cells from the human myeloid lineage, and that provides an in vivo stem cell assay for human hematopoietic cells is described. Generation of the chimeric human/immune-deficient (HID) mice was dependent on the use of immune-deficient bg/nu/xid mice. Infusion of these mice with human bone marrow gave rise to increases in human macrophage progenitors during more than 5 weeks of in vivo growth, indicating the seeding, proliferation, and differentiation of human stem cells. The human identity of the progenitors was confirmed by sequence analysis and their dependence on human growth factors. The creation of HID mice lays the foundation for establishing animal models for a wide variety of human hemopathies, from leukemia to infectious disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904703     DOI: 10.1126/science.2904703

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  82 in total

Review 1.  Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

Authors:  Todd Meyerrose; Scott Olson; Suzanne Pontow; Stefanos Kalomoiris; Yunjoon Jung; Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Adv Drug Deliv Rev       Date:  2010-10-13       Impact factor: 15.470

2.  In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.

Authors:  D M Neville; J Scharff; K Srinivasachar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 3.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

5.  Role of Polycomb-group genes in sustaining activities of normal and malignant stem cells.

Authors:  Yoshihiro Takihara
Journal:  Int J Hematol       Date:  2007-11-30       Impact factor: 2.490

Review 6.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

Review 7.  Cancer stem cells: relevance to SCT.

Authors:  T Lin; R J Jones; W Matsui
Journal:  Bone Marrow Transplant       Date:  2009-02-23       Impact factor: 5.483

Review 8.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

Review 9.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

10.  Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus.

Authors:  S Reina; P Markham; E Gard; F Rayed; M Reitz; R C Gallo; O E Varnier
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.